Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Roche Holding AG

RHO6
Current price
34.28 EUR 0 EUR (0.00%)
Last closed 282 CHF
ISIN CH0012032113
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Stuttgart Exchange
Capitalization 210 489 606 144 CHF
Yield for 12 month +4.96 %
1Y
3Y
5Y
10Y
15Y
RHO6
21.11.2021 - 28.11.2021

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland. Address: Grenzacherstrasse 124, Basel, Switzerland, 4058

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

216.1 CHF

P/E ratio

21.2981

Dividend Yield

3.4 %

Current Year

+58 716 000 000 CHF

Last Year

+63 281 000 000 CHF

Current Quarter

+29 848 000 000 CHF

Last Quarter

+28 937 000 000 CHF

Current Year

+42 898 000 000 CHF

Last Year

+44 444 000 000 CHF

Current Quarter

+21 978 000 000 CHF

Last Quarter

+20 657 000 000 CHF

Key Figures RHO6

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 21 041 000 448 CHF
Operating Margin TTM 35.27 %
PE Ratio 21.2981
Return On Assets TTM 12.49 %
PEG Ratio 1.3062
Return On Equity TTM 36.36 %
Wall Street Target Price 216.1 CHF
Revenue TTM 60 580 999 168 CHF
Book Value 36.32 CHF
Revenue Per Share TTM
Dividend Share 9.6 CHF
Quarterly Revenue Growth YOY 0.5 %
Dividend Yield 3.4 %
Gross Profit TTM 47 828 000 000 CHF
Earnings per share 13.25 CHF
Diluted Eps TTM 13.25 CHF
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -12.1 %
Profit Margin 17.53 %

Dividend Analytics RHO6

Aristocrat - 25 or more consecutive years of dividend increases

Dividend growth over 5 years

14 %

Continuous growth

28 years

Payout Ratio 5 years average

57 %

Dividend History RHO6

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 9.6
Ex Dividend Date 14.03.2024
Forward Annual Dividend Yield 3.4 %
Last Split Factor 100:1
Payout Ratio 116.36 %
Last Split Date 04.05.2011
Dividend Date 18.03.2024

Stock Valuation RHO6

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 21.2981
Forward PE 13.8504
Enterprise Value Revenue 3.8951
Price Sales TTM 3.4745
Enterprise Value EBITDA 13.324
Price Book MRQ 7.7636

Financials RHO6

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RHO6

For 52 weeks

226.91 CHF 312 CHF
50 Day MA 296.9 CHF
Shares Short Prior Month
200 Day MA 266.78 CHF
Short Ratio
Shares Short
Short Percent